# Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ramucirumab-plus-docetaxel-versus-placebo-plus-docetaxel-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniel P. Petrylak,Ronald de Wit,Kim N.,Alexandra Drakaki,Cora N. Sternberg,Hiroyuki Nishiyama,Daniel Castellano,Syed A. Hussain,Aude Fléchon,Aristotelis Bamias,Evan Y. Yu,Michiel S. van der Heijden,Nobuaki Matsubara,B. Yа. Alekseev,Andrea Necchi,Lajos Géczi,Yen‐Chuan Ou,Hasan Şenol Çoşkun,Wen-Pin Su,Miriam Hegemann,Ivor Percent,Jae‐Lyun Lee,Marcello Tucci,Andrey Semenov,Fredrik Laestadius,Avivit Peer,Giampaolo Tortora,Sufia Safina,Xavier García del Muro,Alejo Rodríguez‐Vida,İrfan Çiçin,Hakan Harputluoğlu,Ryan C. Widau,Astra M. Liepa,Richard A. Walgren,Oday Hamid,Annamaria H. Zimmermann,Katherine M. Bell‐McGuinn,Thomas Powles,Suet-Lai Shirley Wong,Thean Hsiang Tan,Elizabeth Hovey,Timothy Clay,Siobhan Ng,Annemie Rutten,Jean‐Pascal Machiels,Herlinde Dumez,Susanna Y. Cheng,Kim Nguyen,Cristiano Ferrario,Lisa Sengeloev,Niels Viggo Jensen,Constance Thibault,Brigitte Laguerre,Fredrik Laestadius,Florence Joly,Aude Fléchon,Stéphane Culine,Catherine Becht,Günter Niegisch,Michael Stöckle,Marc‐Oliver Grimm,Georgios Gakis,Wolfgang Schultze‐Seemann,Haralambos Kalofonos,Dimitriοs Mavroudis,Christos N. Papandreou,Vasilis Karavasilis,Aristotelis Bamias,János Révész,Lajos Géczi,Eli Rosenbaum,Raya Leibowitz‐Amit,Daniel Kejzman,Avivit Peer,David Sarid,Giorgio V. Scagliotti,Cora N. Sternberg,Giampaolo Tortora,Sergio Bracarda,Andrea Necchi,Francesco Massari,Takahiro Osawa,Naoto Miyajima,Nobuo Shinohara,Fumimasa Fukuta,Chikara Οhyama,Wataru Obara,Shinichi Yamashita,Yoshihiko Tomita,Koji Kawai,Satoshi Fukasawa,Nobuaki Matsubara,Masafumi Oyama,Junji Yonese,Masayoshi Nagata,Motohide Uemura,Kazuo Nishimura,Mutsushi Kawakita,Hiroyuki Tsunemori |
| Citations | 177 |
| DOI | 10.1016/s0140-6736(17)32365-6 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/10026.1/10985 |
| OpenAlex ID | https://openalex.org/W2755607580 |
| PMID | 28916371 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Kim N.](https://scholariq.org/researchers/kim-n/)
- [Takahiro Osawa](https://scholariq.org/researchers/takahiro-osawa/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Paper topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.